Collaboration between Dialysis Providers

Jeffrey Silberzweig^{1

2}, J Ganesh Bhat^{3

4}, Mary O Dittrich⁵, Raghu Durvasula⁶, Jeff Giullian⁷, Jeffrey L Hymes⁸, Doug Johnson⁹, Brigitte Schiller^{10

11}, Richard Spech¹², Leslie Spry¹³, Geoffrey Scott Walker¹⁴, Suzanne Watnick^{15

16}, Jerry Yee^{17

18}, Barry I Freedman^{19

20}

Affiliations

¹ The Rogosin Institute, New York, New York.
² Department of Medicine, Weill Cornell Medical College, New York, New York.
³ Atlantic Dialysis Management Services, New York, New York.
⁴ Xavier University School of Medicine, Oranjestad, Aruba.
⁵ US Renal Care, Plano, Texas.
⁶ Puget Sound Kidney Centers, Everett, Washington.
⁷ DaVita, Inc., Denver, Colorado.
⁸ Fresenius Kidney Care, Waltham, Massachusetts.
⁹ Dialysis Clinic, Inc., Nashville, Tennessee.
¹⁰ Satellite Healthcare, San Jose, California.
¹¹ Division of Nephrology, Stanford University, Palo Alto, California.
¹² Centers for Dialysis Care, Cleveland, Ohio.
¹³ Dialysis Centers of Lincoln, Lincoln, Nebraska.
¹⁴ Medical Advisory Committee, American Renal Associates, Beverly, Massachusetts.
¹⁵ Northwest Kidney Centers, Seattle, Washington.
¹⁶ University of Washington, Seattle, Washington.
¹⁷ Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan.
¹⁸ Greenfield Health Systems, Detroit, Michigan.
¹⁹ Health Systems Management, Inc., Tifton, Georgia.
²⁰ Internal Medicine/Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Jeffrey Silberzweig et al. J Am Soc Nephrol. 2022 Aug.

. 2022 Aug;33(8):1440-1444.

doi: 10.1681/ASN.2021111475. Epub 2022 Jun 2.

¹ The Rogosin Institute, New York, New York.
² Department of Medicine, Weill Cornell Medical College, New York, New York.
³ Atlantic Dialysis Management Services, New York, New York.
⁴ Xavier University School of Medicine, Oranjestad, Aruba.
⁵ US Renal Care, Plano, Texas.
⁶ Puget Sound Kidney Centers, Everett, Washington.
⁷ DaVita, Inc., Denver, Colorado.
⁸ Fresenius Kidney Care, Waltham, Massachusetts.
⁹ Dialysis Clinic, Inc., Nashville, Tennessee.
¹⁰ Satellite Healthcare, San Jose, California.
¹¹ Division of Nephrology, Stanford University, Palo Alto, California.
¹² Centers for Dialysis Care, Cleveland, Ohio.
¹³ Dialysis Centers of Lincoln, Lincoln, Nebraska.
¹⁴ Medical Advisory Committee, American Renal Associates, Beverly, Massachusetts.
¹⁵ Northwest Kidney Centers, Seattle, Washington.
¹⁶ University of Washington, Seattle, Washington.
¹⁷ Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan.
¹⁸ Greenfield Health Systems, Detroit, Michigan.
¹⁹ Health Systems Management, Inc., Tifton, Georgia.
²⁰ Internal Medicine/Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

No abstract available

Keywords: COVID-19; dialysis; end stage kidney disease; outcomes; patient-centered care.

References

1. Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, et al. : COVID-19 among US dialysis patients: Risk factors and outcomes from a national dialysis provider. Am J Kidney Dis 77: 748–756.e1, 2021 - PMC - PubMed
1. Anand S, Montez-Rath M, Han J, Bozeman J, Kerschmann R, Beyer P, et al. : Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: A cross-sectional study. Lancet 396: 1335–1344, 2020 - PMC - PubMed
1. Weinhandl ED, Wetmore JB, Peng Y, Liu J, Gilbertson DT, Johansen KL: Initial effects of COVID-19 on patients with ESKD. J Am Soc Nephrol 32: 1444–1453, 2021 - PMC - PubMed
1. Mohan S, King KL, Husain SA, Schold JD: COVID-19-associated mortality among kidney transplant recipients and candidates in the United States. Clin J Am Soc Nephrol 16: 1695–1703, 2021 - PMC - PubMed
1. Kliger AS, Silberzweig J: Mitigating risk of COVID-19 in dialysis facilities. Clin J Am Soc Nephrol 15: 707–709, 2020 - PMC - PubMed